Because both LPL and GLUT1 are considered poor prognosis factors of HCC (29, 31, 32), dual-tracer PET/CT imaging might be used to unveil the metabolic status of HCC to predict the prognosis of patients with HCC. The gene discussed is LPL; the disease is hepatocellular carcinoma.